Nicole Sweeny - 12 Feb 2023 Form 4 Insider Report for Praxis Precision Medicines, Inc. (PRAX)

Reporting relationship: Chief Commercial Officer
Issuer ticker: PRAX
Reported as of: 12 Feb 2023
Net transaction value: -$5,737
SEC form: 4
Accepted by SEC: 13 Feb 2023, 19:50:24 UTC
Prior SEC filing: 13 Jan 2023
Next SEC filing: 25 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Alex Nemiroff, as Attorney-in-Fact

Key filing fact

Nicole Sweeny filed Form 4 for Praxis Precision Medicines, Inc. (PRAX) on 13 Feb 2023.

Key facts

This page summarizes Nicole Sweeny's Form 4 filing for Praxis Precision Medicines, Inc. (PRAX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 13 Feb 2023, 19:50.

Change

Previous filing in this sequence was filed on 13 Jan 2023.
Current net transaction value: -$5,737.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRAX transaction

Common Stock

Tax liability

Transaction value: $5,737
Shares: -1,456
Change %: -3.6%
Price: $3.94
Shares after: 38,619
Date: 12 Feb 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units.